Search results
Results from the WOW.Com Content Network
The following findings are required, by section 202 of that Act, for substances to be placed in this schedule: The drug or other substance has a high potential for abuse. The drug or other substance has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.
1.1 Crude opiate extracts whole opium products. ... 1.3.2 3,6-diesters of morphine. ... Download as PDF; Printable version; In other projects
Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium [3] [note 1] 9804 Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, nonnarcotic ingredients in ...
It may be used as a precursor in one of the chemical reactions at the final stage of formation of a chemical listed in Schedule 1 or Schedule 2, part b; It poses a significant risk to the object and purpose of this Convention by virtue of its importance in the production of a chemical listed in Schedule 1 or Schedule 2, part A;
Download as PDF; Printable version; In other projects ... Schedule 2 may refer to: Second Schedule of the ... 12 (UTC). Text is ...
The Schedule 3 list is one of three lists. Chemicals which can be used as weapons, or used in their manufacture, but which have no, or almost no, legitimate applications as well are listed in Schedule 1, whilst Schedule 2 is used for chemicals which have legitimate small-scale applications. The use of Schedule 1, 2, or 3 chemicals as weapons is ...
In clinical practice, this mostly applies to the use of strong opiates for pain management and some amphetamine-like stimulants used for Attention-deficit hyperactivity disorder; both of which are regulated under Schedule 2. The Royal Pharmaceutical Society maintains a live database of the legal classification of medicines. [1]
For example, in NSW the prescribing of Schedule 8 CNS stimulant medication (e.g., methylphenidate, dexamfetamine) requires authorisation from the NSW Ministry of Health (Pharmaceutical Services) and is generally restricted to specialists, such as paediatricians and psychiatrists.